Display options
Share it on

Mediators Inflamm. 1997;6(5):355-61. doi: 10.1080/09629359791497.

The effect of ozone exposure on the release of eicosanoids in guinea-pig BAL fluid in relation to cellular damage and inflammation.

Mediators of inflammation

H J van Hoof, F J Zijlstra, H P Voss, I M Garrelds, J A Dormans, L van Bree, A Bast

Affiliations

  1. Leiden/Amsterdam Center for Drug Research, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, Amsterdam 1081 HV, The Netherlands. [email protected]

PMID: 18472870 PMCID: PMC2365875 DOI: 10.1080/09629359791497

Abstract

The observed effects after ozone exposure strongly depend on ozone concentration and exposure time. We hypothesized that depending on the O3 exposure protocol, mainly either an oxidant damage or an inflammation will determine the O3 toxicity. We compared two different ozone exposure protocols: an acute exposure (3 ppm 2 h) for studying the oxidant damage and an exposure (1 ppm 12 h) where an inflammatory component is also probably involved. We measured LDH activity and protein and albumin exudation as markers for cellular damage. After the acute exposure an increase in LDH activity was measured and after exposure to 1 ppm ozone for 12 h the exudation of protein and albumin was also enhanced. The histological examinations showed a neutrophilic inflammatory response only after exposure to 1 ppm ozone for 12 h. The acute exposure protocol resulted in an increased release of PGE2, PGD2, PGF2alpha and 6-ketoPGF1alpha whereas exposure to 1 ppm ozone for 12 h led to an additional release of LTB4. No effects were measured on the release of TxB2 and LTC4/D4/E4. These changed amounts of eicosanoids will probably contribute to the ozone-induced lung function changes.

References

  1. J Appl Physiol (1985). 1985 Dec;59(6):1941-6 - PubMed
  2. Ann N Y Acad Sci. 1988;524:282-8 - PubMed
  3. Respir Med. 1997 Jan;91(1):47-55 - PubMed
  4. Toxicol Appl Pharmacol. 1996 May;138(1):176-85 - PubMed
  5. Proc Natl Acad Sci U S A. 1979 May;76(5):2148-52 - PubMed
  6. Pharmacol Rev. 1988 Mar;40(1):49-84 - PubMed
  7. J Appl Physiol (1985). 1986 Apr;60(4):1321-6 - PubMed
  8. Biochim Biophys Acta. 1988 Dec 16;963(3):401-13 - PubMed
  9. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994-8 - PubMed
  10. Am J Respir Cell Mol Biol. 1991 Jan;4(1):72-81 - PubMed
  11. Br Med Bull. 1992 Jan;48(1):51-64 - PubMed
  12. Toxicology. 1996 Dec 18;114(3):187-97 - PubMed
  13. Eur J Pharmacol. 1992 Dec 15;229(2-3):171-8 - PubMed
  14. Am Rev Respir Dis. 1983 Jun;127(6):686-90 - PubMed
  15. J Pharmacol Exp Ther. 1992 Feb;260(2):789-94 - PubMed
  16. Toxicol Lett. 1994 Feb 1;70(2):203-9 - PubMed
  17. Am Rev Respir Dis. 1991 Jan;143(1):188-203 - PubMed
  18. Trends Pharmacol Sci. 1991 Apr;12(4):158-63 - PubMed
  19. Am Rev Respir Dis. 1985 Mar;131(3):314-20 - PubMed
  20. Free Radic Biol Med. 1990;9(3):245-65 - PubMed
  21. J Lipid Mediat. 1993 Mar-Apr;6(1-3):275-86 - PubMed
  22. Lung. 1994;172(3):169-81 - PubMed
  23. Agents Actions. 1991 Sep;34(1-2):270-3 - PubMed
  24. Am Rev Respir Dis. 1990 Feb;141(2):471-501 - PubMed
  25. Am Rev Respir Dis. 1993 Nov;148(5):1363-72 - PubMed
  26. J Clin Invest. 1984 Apr;73(4):889-97 - PubMed
  27. Acta Histochem. 1990;89(1):81-4 - PubMed
  28. Am J Pathol. 1980 Mar;98(3):811-40 - PubMed

Publication Types